US Patent 7342092 Cancer antigen peptide formulations
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+216 characters)
Article
Patent abstract
Cancer antigen peptides derived from WT1 which have an in vivo efficacy, particularly a clinical usefulness, and cancer vaccines as dosage forms suitable for said cancer antigen peptides, are provided.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07342092 Cancer antigen peptide formulations US Patent 7342092 Cancer antigen peptide formulations
Infobox
Patent Number
0734209200
Patent Number
734209200
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073420920
Date of Patent
March 11, 2008
0Patent Application Number
105276920
Date Filed
September 12, 2003
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073420920
Date of Patent
March 11, 2008
0Patent Application Number
105276920
Date Filed
September 12, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07342092 Cancer antigen peptide formulations
Infobox
Is a
Patent jurisdiction
Patent number
07342092
Date of patent
March 11, 2008
Patent application number
10527692
Date Filed
September 12, 2003
Patent primary examiner
Find more entities like US Patent 7342092 Cancer antigen peptide formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.